Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
—
—
—
Par Drugs and Chemicals provides generic drugs. The Company is engaged in the development and manufacturing of Active Pharma Ingredients (APIs) for the domestic market, as well as for exports to international markets
Customise key metrics, see detailed forecasts, download stock data and more
Pledged promoter holdings is insignificant
In last 3 months, mutual fund holding of the company has almost stayed constant
Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on December 02, 2024 through Video Conferencing ("VC") mode. The Board meeting was commenced at 04:00 pm and concluded at 05:28 pm | Download
Par Drugs And Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on December 02, 2024 through Video Conferencing ("VC") mode. The Board meeting was commenced at 04:00 pm and concluded at 05:28 pm | Download
Interim • Div/Share: ₹ 1.25
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant